دورية أكاديمية

Post-COVID-19 Fetal Cardiac Morphology and Systolic Evaluation in Infected Pregnant Women by Fetal Heart Quantification Technology.

التفاصيل البيبلوغرافية
العنوان: Post-COVID-19 Fetal Cardiac Morphology and Systolic Evaluation in Infected Pregnant Women by Fetal Heart Quantification Technology.
المؤلفون: Zhu F; Ultrasonic Department, The Third Affiliated Hospital of Zhengzhou University (Maternal and Child Health Hospital of Henan Province), Zhengzhou, China., Zhao Y; Prenatal Diagnosis Center, The Third Affiliated Hospital of Zhengzhou University (Maternal and Child Health Hospital of Henan Province), Zhengzhou, China., Wu J; Ultrasonic Department, The Third Affiliated Hospital of Zhengzhou University (Maternal and Child Health Hospital of Henan Province), Zhengzhou, China., Wang M; Ultrasonic Department, The Third Affiliated Hospital of Zhengzhou University (Maternal and Child Health Hospital of Henan Province), Zhengzhou, China., Zhu Z; Ultrasonic Department, The Third Affiliated Hospital of Zhengzhou University (Maternal and Child Health Hospital of Henan Province), Zhengzhou, China., Zhang L; Ultrasonic Department, The Third Affiliated Hospital of Zhengzhou University (Maternal and Child Health Hospital of Henan Province), Zhengzhou, China.
المصدر: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine [J Ultrasound Med] 2024 Jul; Vol. 43 (7), pp. 1199-1209. Date of Electronic Publication: 2024 Mar 11.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: John Wiley and Sons Country of Publication: England NLM ID: 8211547 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-9613 (Electronic) Linking ISSN: 02784297 NLM ISO Abbreviation: J Ultrasound Med Subsets: MEDLINE
أسماء مطبوعة: Publication: 2017- : Oxford, UK : John Wiley and Sons
Original Publication: [Philadelphia, Pa.] : W.B. Saunders, c1982-
مواضيع طبية MeSH: COVID-19*/diagnostic imaging , COVID-19*/physiopathology , COVID-19*/complications , Fetal Heart*/diagnostic imaging , Fetal Heart*/physiopathology , Pregnancy Complications, Infectious*/diagnostic imaging , Pregnancy Complications, Infectious*/physiopathology , Ultrasonography, Prenatal*/methods , Echocardiography*/methods, Humans ; Female ; Pregnancy ; Adult ; Prospective Studies ; SARS-CoV-2 ; Systole ; China/epidemiology
مستخلص: Objectives: Due to the government's liberalization of epidemic control, the current 2019 novel coronavirus disease (COVID-19) has started to spread widely within China. This study aimed to use the fetal heart quantification (fetal HQ) technique to assess the cardiac function and morphology of the fetuses of pregnant women diagnosed with COVID-19 in the early stages of pregnancy.
Methods: Exactly 86 pregnant women diagnosed with COVID-19 infection in early pregnancy (COVID-19 group) and 90 healthy pregnant women (control group) who underwent fetal echocardiography were prospectively included in this study. The fetal HQ technique was applied to compare the differences in the global sphericity index (GSI), global strain values (GS), fractional area change (FAC), and 24-segment fractional shortening (FS) of the left and right ventricles, between the COVID-19 group and the control group.
Results: Compared with the control group, the differences in GS and 24-segment FS of the left ventricle in the COVID-19 group were not statistically significant. However, the COVID-19 group showed lower GSI values compared with the control group (1.24 vs 1.28). FAC (48.12%) of the left ventricle and GS (-23.55%), FAC (41.74%) of the right ventricle in the COVID-19 group were reduced compared with FAC (50.50%) of the left ventricle and GS (-27.63%), FAC (46.01%) of the right ventricle in the control group. Segmental analysis revealed reduced FS in segments 20-24 in the COVID-19 group compared with the control group. Right ventricular GS was an independent predictor of adverse pregnancy outcome with an optimal cutoff value of -18.66%.
Conclusions: The results suggest that COVID-19 infection in early pregnancy may have a negative impact on fetal cardiac morphology and function. Fetal HQ may offer a new assessment method for the early identification of fetal cardiac alterations in pregnant women infected with COVID-19.
(© 2024 The Authors. Journal of Ultrasound in Medicine published by Wiley Periodicals LLC on behalf of American Institute of Ultrasound in Medicine.)
References: Hamidi OP, Lijewski V, Sheeder J, et al. Adverse perinatal outcomes in pregnancies affected by severe COVID‐19 infection. AJOG Glob Rep 2022; 2:100–118.
Mullins E, Perry A, Banerjee J, et al. Pregnancy and neonatal outcomes of COVID‐19: the PAN‐COVID study. Eur J Obstet Gynecol Reprod Biol 2022; 276:161–167.
Conde‐Agudelo A, Romero R. SARS‐CoV‐2 infection during pregnancy and risk of preeclampsia: a systematic review and meta‐analysis. Am J Obstet Gynecol 2022; 226:68–89.
Garrido‐Pontnou M, Navarro A, Camacho J, et al. Diffuse trophoblast damage is the hallmark of SARS‐CoV‐2‐associated fetal demise. Mod Pathol 2021; 34:1704–1709.
Hecht JL, Quade B, Deshpande V, et al. SARS‐CoV‐2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID‐19‐positive mothers. Mod Pathol 2020; 33:2092–2103.
Yuan SM. Fetal arrhythmias: genetic background and clinical implications. Pediatr Cardiol 2019; 40:247–256.
Li Yanfei H, Hairui W, Fang T, et al. A preliminary study on the evaluation of fetal heart shapeusing quantitative fetal heart analysis. Chinese. J Ultrasound Med 2021; 37:1032–1035.
DeVore GR, Klas B, Satou G, Sklansky M. 24‐segment sphericity index: a new technique to evaluate fetal cardiac diastolic shape: 24‐segment sphericity index. Ultrasound Obstet Gynecol 2018; 51:650–658.
World Health Organization. Guideline Clinical Management of COVID‐19: Living Guideline. Accessed August 18, 2023. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2023.2.
World Health Organization. Guidelines on Basic Newborn Resuscitation. Accessed January 1, 2012. https://www.who.int/publications/i/item/9789241503693.
DeVore GR, Satou G, Sklansky M. Abnormal fetal findings associated with a global sphericity index of the 4‐chamber view below the 5th centile: global sphericity index of the 4‐chamber view below the 5th centile. J Ultrasound Med 2017; 36:2309–2318.
Coyne CB, Lazear HM. Zika virus—reigniting the TORCH. Nat Rev Microbiol 2016; 14:707–715.
Weckman AM, Ngai M, Wright J, McDonald CR, Kain KC. The impact of infection in pregnancy on placental vascular development and adverse birth outcomes. Front Microbiol 2019; 10:1–11.
Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS‐CoV‐2 spike glycoprotein. Cell 2020; 181:281–292.
Murlewska J, Sylwestrzak O, Respondek‐Liberska M, Sklansky M, Devore G. Longitudinal surveillance of fetal heart failure using speckle tracking analysis. J Clin Med 2022; 11:7102.
Nogué L, Gómez O, Izquierdo N, et al. Feasibility of 4D‐spatio temporal image correlation (STIC) in the comprehensive assessment of the fetal heart using FetalHQ®. J Clin Med 2022; 11:1414.
Turgut E, Ayhan SG, Oluklu D, Tokalioglu EO, Tekin OM, Sahin D. Fetal pulmonary artery Doppler evaluation in pregnant women after recovery from COVID‐19. Int J Gynecol Obstet 2021; 155:450–454.
Turgut E, Sakcak B, Uyan Hendem D, Oluklu D, Goncu Ayhan S, Sahin D. Decreased fetal cardiac output in pregnant women with severe SARS‐Cov‐2 infection. Echocardiography 2022; 39:803–810.
Goncu Ayhan S, Turgut E, Ozden Tokalioglu E, et al. Post‐COVID‐19 fetal cardiac evaluation in moderate infection group of pregnant women. J Clin Ultrasound 2022; 50:630–635.
Wang D, Liu C, Liu X, Zhang Y, Wang Y. Evaluation of prenatal changes in fetal cardiac morphology and function in maternal diabetes mellitus using a novel fetal speckle‐tracking analysis: a prospective cohort study. Cardiovasc Ultrasound 2021; 19:25.
Harbison AL, Pruetz JD, Ma S, Sklansky MS, Chmait RH, DeVore GR. Evaluation of cardiac function in the recipient twin in successfully treated twin‐to‐twin transfusion syndrome using a novel fetal speckle‐tracking analysis. Prenat Diagn 2021; 41:136–144.
Di Donato M, Menicanti L, Ranucci M, et al. Effects of surgical ventricular reconstruction on diastolic function at midterm follow‐up. J Thorac Cardiovasc Surg 2010; 140:285–291.
Cruz‐Lemini M, Crispi F, Valenzuela‐Alcaraz B, et al. Fetal cardiovascular remodeling persists at 6 months in infants with intrauterine growth restriction: fetal cardiovascular remodeling persists in IUGR infants. Ultrasound Obstet Gynecol 2016; 48:349–356.
Chen Y, Chen Q, Wu Y, et al. Fetal cardiac geometry and function in pregnancies with well‐controlled gestational diabetes mellitus using Fetal HQ. J Matern Fetal Neonatal Med 2022; 35:8331–8337.
Anuk AT, Tanacan A, Yetiskin FDY, et al. Doppler assessment of the fetus in pregnant women recovered from COVID‐19. J Obstet Gynaecol Res 2021; 47:1757–1762.
Parra‐Saavedra M, Crovetto F, Triunfo S, et al. Association of Doppler parameters with placental signs of underperfusion in late‐onset small‐for‐gestational‐age pregnancies: placental underperfusion in late‐onset SGA pregnancies. Ultrasound Obstet Gynecol 2014; 44:330–337.
Mebius MJ, Clur SAB, Vink AS, et al. Growth patterns and cerebroplacental hemodynamics in fetuses with congenital heart disease. Ultrasound Obstet Gynecol 2019; 53:769–778.
Prior T, Mullins E, Bennett P, Kumar S. Prediction of intrapartum fetal compromise using the cerebroumbilical ratio: a prospective observational study. Am J Obstet Gynecol 2013; 208:124.e1–124.e6.
García‐Otero L, Gómez O, Rodriguez‐López M, et al. Nomograms of fetal cardiac dimensions at 18‐41 weeks of gestation. Fetal Diagn Ther 2020; 47:387–398.
DeVore GR, Gumina DL, Hobbins JC. Assessment of ventricular contractility in fetuses with an estimated fetal weight less than the tenth centile. Am J Obstet Gynecol 2019; 221:498.e1–498.e22.
Bhorat IE, Bagratee JS, Pillay M, Reddy T. Use of the myocardial performance index as a prognostic indicator of adverse fetal outcome in poorly controlled gestational diabetic pregnancies: myocardial performance index as a prognostic indicator of adverse outcome in poorly controlled gestational diabetic pregnancies. Prenat Diagn 2014; 34:1301–1306.
معلومات مُعتمدة: 2023GJZ03 The Basic Research Funds of Central Public Welfare Research Institutes of China; 62027827 The National Natural Science Foundation of China
فهرسة مساهمة: Keywords: COVID‐19; SARS‐COV‐2; echocardiography; fetal heart quantification; fetus; speckle‐tracking
تواريخ الأحداث: Date Created: 20240311 Date Completed: 20240617 Latest Revision: 20240617
رمز التحديث: 20240617
DOI: 10.1002/jum.16444
PMID: 38465462
قاعدة البيانات: MEDLINE
الوصف
تدمد:1550-9613
DOI:10.1002/jum.16444